Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer.

Zhou X, Zhu Y, Wang W, Cai Y, Liu Z, Su Y, Ma S

Open source

DOI
10.1016/j.xpro.2026.104706
Published
2026 Jul 17
Container
STAR protocols
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xpro.2026.104706,
  title = {Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer.},
  author = {Zhou X and Zhu Y and Wang W and Cai Y and Liu Z and Su Y and Ma S},
  year = {2026},
  journal = {STAR protocols},
  doi = {10.1016/j.xpro.2026.104706},
  url = {https://doi.org/10.1016/j.xpro.2026.104706}
}

RIS

TY  - JOUR
TI  - Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer.
AU  - Zhou X
AU  - Zhu Y
AU  - Wang W
AU  - Cai Y
AU  - Liu Z
AU  - Su Y
AU  - Ma S
PY  - 2026
JO  - STAR protocols
DO  - 10.1016/j.xpro.2026.104706
UR  - https://doi.org/10.1016/j.xpro.2026.104706
ER  - 

APA

X, Z., Y, Z., W, W., Y, C., Z, L., Y, S., & S, M. (2026). Protocol for high-throughput droplet-engineered TIL-retaining tumor organoids in triple-negative breast cancer.. STAR protocols. https://doi.org/10.1016/j.xpro.2026.104706

Source records